loading
Schlusskurs vom Vortag:
$1.70
Offen:
$1.71
24-Stunden-Volumen:
605.80K
Relative Volume:
1.32
Marktkapitalisierung:
$55.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-1.2174
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
+9.09%
1M Leistung:
+7.01%
6M Leistung:
+5.00%
1J Leistung:
-48.31%
1-Tages-Spanne:
Value
$1.64
$1.75
1-Wochen-Bereich:
Value
$1.52
$1.78
52-Wochen-Spanne:
Value
$1.40
$3.48

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Name
Firmenname
MAIA Biotechnology Inc
Name
Telefon
312 416 8592
Name
Adresse
444 West Lake Street, Suite 1700, Chicago
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
MAIA's Discussions on Twitter

Vergleichen Sie MAIA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MAIA
MAIA Biotechnology Inc
1.68 51.47M 0 -25.94M -15.79M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.53 99.62B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.89 61.52B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.00 58.91B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.38 46.69B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
324.34 34.54B 3.81B -644.79M -669.77M -6.24

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

pulisher
05:44 AM

Will breakout in MAIA Biotechnology Inc. lead to full recoveryTrade Entry Report & Reliable Price Breakout Signals - Newser

05:44 AM
pulisher
05:40 AM

How hedge fund analytics apply to MAIA Biotechnology Inc. stock2025 Price Action Summary & Safe Entry Trade Reports - Newser

05:40 AM
pulisher
Sep 12, 2025

How to integrate MAIA Biotechnology Inc. into portfolio analysis tools2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What the charts say about MAIA Biotechnology Inc. todayEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Short interest data insights for MAIA Biotechnology Inc.Market Movers & Low Drawdown Momentum Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

MAIA Biotechnology Updates Business Presentation Online - TipRanks

Sep 12, 2025
pulisher
Sep 12, 2025

MAIA Biotechnology Inc. stock volume spike explainedPortfolio Performance Report & Daily Profit Focused Stock Screening - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What Fibonacci levels say about MAIA Biotechnology Inc. rebound2025 Market Trends & Technical Buy Zone Confirmation - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What earnings revisions data tells us about MAIA Biotechnology Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Published on: 2025-09-12 05:24:13 - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using economic indicators to assess MAIA Biotechnology Inc. potentialQuarterly Trade Report & Proven Capital Preservation Methods - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using portfolio simulators with MAIA Biotechnology Inc. included2025 Market WrapUp & Safe Entry Zone Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is a relief rally coming for MAIA Biotechnology Inc. holdersJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will earnings trigger a reversal in MAIA Biotechnology Inc.Weekly Trend Summary & Community Driven Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

What recovery options are there for MAIA Biotechnology Inc.Long Setup & Accurate Technical Buy Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

MAIA Biotechnology Reports Positive Phase 2 Trial Results - TipRanks

Sep 11, 2025
pulisher
Sep 11, 2025

MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer - The Manila Times

Sep 11, 2025
pulisher
Sep 11, 2025

MAIA Biotechnology Highlights Positive Efficacy Data from - GlobeNewswire

Sep 11, 2025
pulisher
Sep 11, 2025

124% Survival Improvement: MAIA Biotechnology's Lung Cancer Drug Doubles Standard Care Effectiveness - Stock Titan

Sep 11, 2025
pulisher
Sep 11, 2025

Intraday pattern recognizer results for MAIA Biotechnology Inc.Market Activity Report & Expert-Curated Trade Recommendations - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Heatmap analysis for MAIA Biotechnology Inc. and competitorsQuarterly Trade Summary & Precise Swing Trade Alerts - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Published on: 2025-09-10 00:28:01 - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Is MAIA Biotechnology Inc. reversing from oversold territoryJuly 2025 Reactions & High Conviction Investment Ideas - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Comparing MAIA Biotechnology Inc. in custom built stock radarsJuly 2025 Levels & Accurate Intraday Trading Signals - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Is MAIA Biotechnology Inc. stock a growth or value playWeekly Trade Recap & Stock Portfolio Risk Management - Newser

Sep 10, 2025
pulisher
Sep 09, 2025

Strategies to average down on MAIA Biotechnology Inc.Weekly Trade Review & Verified Technical Signals - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Does MAIA Biotechnology Inc. have pricing powerWatch List & Safe Capital Growth Plans - Lancaster City Council

Sep 09, 2025
pulisher
Sep 09, 2025

Has MAIA Biotechnology Inc. formed a bullish divergenceInsider Selling & Smart Allocation Stock Tips - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

using portfolio simulators with maia biotechnology inc. includedAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Published on: 2025-09-09 02:06:15 - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Order flow analysis tools used on MAIA Biotechnology Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser

Sep 09, 2025
pulisher
Sep 08, 2025

Maia Biotechnology presents Phase 2 THIO-101 trial data at lung cancer conference - Investing.com Australia

Sep 08, 2025

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Kapitalisierung:     |  Volumen (24h):